Vinorelbine Safety Questions, Vinorelbine Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Vinorelbine side effects. Check out Health Surveys and Health Polls. If you have questions about Vinorelbine, you can post them to our Doctors or Ask Patient Community about Vinorelbine.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Vinorelbine
Vinorelbine Safety Reports
Total Vinorelbine reports: 28.Vinorelbine FDA safety alerts: No.
Reported deaths: 11 Reported hospitalizations: 7.
Take Vinorelbine Side Effects Survey or Share Your Vinorelbine Story.
Reported Vinorelbine Side Effects: vomiting, infusion related reaction, dyspnoea, respiratory failure, asthenia, neutropenic sepsis, chest pain, diarrhoea, facial palsy, pneumonia, renal failure.
More About Vinorelbine.
Vinorelbine Side Effects Report #5257329-7
Health Professional from UNITED STATES reported VINORELBINE problem on Sept 12, 2006. Female patient, 51 years of age, weighting 163.1 lb, was diagnosed with breast cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: neuropathy. VINORELBINE dosage: 28 MG. Patient recovered.
Vinorelbine Side Effects Report #5257340-6
VINORELBINE problem was reported by a Health Professional from UNITED STATES on Sept 18, 2006. Female patient, 44 years of age, was diagnosed with breast cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. VINORELBINE dosage: 20 MG/WEEKLY. During the same period patient was treated with HEPARIN, NAPROXEN. Patient was hospitalized. Patient recovered.
Vinorelbine Side Effects Report #5313196-4
Consumer or non-health professional from UNITED KINGDOM reported VINORELBINE problem on Apr 12, 2007. Female patient, 50 years of age, weighting 110.2 lb, was diagnosed with breast cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, dizziness, eye swelling, hypotension, nausea, pyrexia, skin tightness, vomiting. VINORELBINE dosage: 46 MG IV. During the same period patient was treated with HERCEPTIN, BRICANYL, TAMOXIFEN CITRATE. Patient recovered.
Vinorelbine Side Effects Report #5088364-X
VINORELBINE problem was reported by a Physician from ITALY on Aug 10, 2006. Female patient was diagnosed with prostate cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: asthenia. VINORELBINE dosage: 20 MG/M**2; UNK; IV. During the same period patient was treated with VINORELBINE TARTRATE, FLUOROURACIL, LEUCOVORIN CALCIUM, DEXAMETHASONE, METOCLOPRAMIDE. Patient recovered.
Vinorelbine Side Effects Report #5088365-1
Physician from ITALY reported VINORELBINE problem on Aug 10, 2006. Female patient was diagnosed with prostate cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: asthenia. VINORELBINE dosage: 20 MG/M**2;UNK; IV - SEE IMAGE. During the same period patient was treated with VINORELBINE TARTRATE, FLUOROURACIL, LEUCOVORIN CALCIUM, DEXAMETHASONE, METOCLOPRAMIDE. Patient recovered.
Vinorelbine Side Effects Report #5092002-X
VINORELBINE problem was reported by a Health Professional from ITALY on Aug 10, 2006. Female patient, child 4 years of age, was diagnosed with brain stem glioma and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: viith nerve paralysis. VINORELBINE dosage: unknown. Patient recovered.
Vinorelbine Side Effects Report #5101452-4
Consumer or non-health professional from FRANCE reported VINORELBINE problem on Aug 22, 2006. Female patient was diagnosed with neoplasm malignant and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, oedema peripheral. VINORELBINE dosage: 20 MG/M**2; UNK; IV. Patient recovered.
Vinorelbine Side Effects Report #5101455-X
VINORELBINE problem was reported by a Consumer or non-health professional from FRANCE on Aug 22, 2006. Female patient was diagnosed with neoplasm malignant and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure. VINORELBINE dosage: 20 MG/M**2;UNK;IV. Patient recovered.
Vinorelbine Side Effects Report #5105997-2
Physician from UNITED STATES reported VINORELBINE problem on Aug 30, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: respiratory failure. VINORELBINE dosage: 25 MG/M**2;IV. During the same period patient was treated with DOCETAXEL. Patient died.
Vinorelbine Side Effects Report #5106469-1
VINORELBINE problem was reported by a Physician from UNITED STATES on Aug 30, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: conduction disorder, dyspnoea, renal failure. VINORELBINE dosage: 25 MG/M**2; IV. During the same period patient was treated with DOCETAXEL. Patient died.
Vinorelbine Side Effects Report #5106586-6
Physician from UNITED STATES reported VINORELBINE problem on Aug 30, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: pneumonia. VINORELBINE dosage: 25 MG/M**2;IV. During the same period patient was treated with DOCETAXEL. Patient died.
Vinorelbine Side Effects Report #5108607-3
VINORELBINE problem was reported by a Health Professional from JAPAN on Sept 02, 2006. Male patient, 62 years of age, was diagnosed with lung neoplasm malignant and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: muscle abscess, pyomyositis, staphylococcal infection. VINORELBINE dosage: 20 MG/M**2;EVERY DAY. During the same period patient was treated with AMRUBICIN HYDROCHLORIDE. Patient recovered.
Vinorelbine Side Effects Report #5109852-3
Health Professional from UNITED STATES reported VINORELBINE problem on Sept 18, 2006. Female patient, weighting 133.0 lb, was diagnosed with vulval cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: haemoptysis, infusion related reaction, intestinal obstruction, productive cough, sputum discoloured, vomiting. VINORELBINE dosage: 20 MG/M2 D 1,8,15 Q 28 D IV. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.
Vinorelbine Side Effects Report #5142894-0
VINORELBINE problem was reported by a Physician from ITALY on Oct 17, 2006. Male patient, child 8 years of age, was diagnosed with brain stem glioma and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: facial palsy, neoplasm progression. VINORELBINE dosage: 30 MG/M2 PER_CYCLE INJ. Patient recovered.
Vinorelbine Side Effects Report #5142920-9
Physician from ITALY reported VINORELBINE problem on Oct 17, 2006. Female patient, child 4 years of age, was diagnosed with brain stem glioma and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: facial palsy. VINORELBINE dosage: 30 MG/M2 PER_CYCLE INJ. Patient recovered.
Vinorelbine Side Effects Report #5144805-0
VINORELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2006. Male patient, 47 years of age, was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dyspnoea, lung infection, lung infiltration, pain. VINORELBINE dosage: 20 MG/M2 IV. During the same period patient was treated with LAPATINIB. Patient recovered.
Vinorelbine Side Effects Report #5148167-4
Physician from FRANCE reported VINORELBINE problem on Oct 23, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, febrile neutropenia, vomiting. VINORELBINE dosage: 22 MG/M**2;IVBOL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN. Patient recovered.
Vinorelbine Side Effects Report #5148214-X
VINORELBINE problem was reported by a Health Professional from FRANCE on Oct 23, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: anxiety, chest pain, diarrhoea, nausea, vomiting. VINORELBINE dosage: 22 MG/M**2;IVBOL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN. Patient died.
Vinorelbine Side Effects Report #5148229-1
Health Professional from FRANCE reported VINORELBINE problem on Oct 23, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: asthenia, breast cancer metastatic, infusion related reaction, lymphangiosis carcinomatosa, malignant neoplasm progression, pulmonary embolism, stomatitis. VINORELBINE dosage: 22 MG/M**2;IVBOL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN. Patient recovered.
Vinorelbine Side Effects Report #5148757-9
VINORELBINE problem was reported by a Physician from UNITED STATES on Oct 25, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: neutropenic sepsis. VINORELBINE dosage: 20 MG/M**2; UNK; UNK. During the same period patient was treated with CISPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, CHLORIDE, DEXTROSE INFUSION FLUID, MANNITOL. Patient was hospitalized. Patient died.
Vinorelbine Side Effects Report #5148758-0
Physician from UNITED STATES reported VINORELBINE problem on Oct 25, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: neutropenic sepsis. VINORELBINE dosage: 20 MG/M**2; UNK; UNK. During the same period patient was treated with CISPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, CHLORIDE, DEXTROSE INFUSION FLUID, MANNITOL. Patient was hospitalized. Patient died.
Vinorelbine Side Effects Report #5151044-6
VINORELBINE problem was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Female patient, weighting 123.0 lb, was diagnosed with vulval cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: disease progression. VINORELBINE dosage: 20 MG/M2 D 1,8, 15 Q 28 D IV. During the same period patient was treated with VINORELBINE TARTRATE, VINORELBINE TARTRATE, LAPATINIB. Patient died on 10/31/2006.
Vinorelbine Side Effects Report #5152215-5
Health Professional from UNITED KINGDOM reported VINORELBINE problem on Oct 27, 2006. Female patient, 63 years of age, was diagnosed with breast cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: alveolitis, cryptogenic organising pneumonia, metastasis. VINORELBINE dosage: unknown. During the same period patient was treated with AMOXICILLIN, ASPIRIN, CANDESARTAN, DEXAMETHASONE, ERYTHROMYCIN, FUROSEMIDE, MORPHINE, MOVICOL. Patient was hospitalized and became disabled. Patient died.
Vinorelbine Side Effects Report #5398961-X
VINORELBINE problem was reported by a Pharmacist from UNITED STATES on July 24, 2007. Male patient, 87 years of age, weighting 135.0 lb, was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: chest pain, infusion related reaction. VINORELBINE dosage: 42MG IN NS 50ML IV. Patient was hospitalized. Patient recovered.
Vinorelbine Side Effects Report #5468887-1
Consumer or non-health professional from UNITED STATES reported VINORELBINE problem on Sept 17, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: respiratory failure. VINORELBINE dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died.
Vinorelbine Side Effects Report #5468916-5
VINORELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: conduction disorder, dyspnoea, renal failure, respiratory failure. VINORELBINE dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died.
Vinorelbine Side Effects Report #5468932-3
Consumer or non-health professional from UNITED STATES reported VINORELBINE problem on Sept 17, 2007. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: pneumonia. VINORELBINE dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died.
Vinorelbine Side Effects Report #5469467-4
VINORELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Male patient, weighting 183.0 lb, was diagnosed with adenoid cystic carcinoma and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: wound dehiscence. VINORELBINE dosage: 31 MG D1,D8,D15/CYCLE 042. During the same period patient was treated with LAPATINIB, OXYCODONE, ZOLPIDEM TARTRATE, NASONEX, BENADRYL, ZOFRAN, ELAVIL, REGLAN. Patient was hospitalized. Patient recovered.